The U.S. health care system saved $313 billion in 2019 from generics and biosimilar drugs, including $96 billion in Medicare savings and $48.5 billion in savings to Medicaid. Read More »
The U.S. Food and Drug Administration (FDA) recently approved Pfizer’s drug XELJANZ (tofacitinib) for treatment of polyarticular course juvenile idiopathic arthritis (pcJIA). Read More »
The American Society of Health-System Pharmacists (ASHP) recently launched its first National Survey of Health-System Specialty Pharmacy Practice, according to a press release by the ASHP. Read More »
The American Society of Health-System Pharmacists (ASHP) recently released a response to a petition calling for an end to gender inequality in the clinical pharmacy industry. Read More »
Pharmaceutical Research and Manufacturers of America President and CEO Stephen Ubl said the biopharmaceutical industry is confident it will beat COVID-19 as it ensures the highest standards in research, testing and manufacturing a vaccine for the virus. Read More »
Expanding Board of Directors to Add to Commercial Expertise Read More »
The American Pharmacists Association and 12 other pharmacy organizations told a special committee of the National Academies of Science, Engineering and Medicine (NASEM) that pharmacists should be given tier 1 priority status in the allocation and distribution of COVID-19 vaccine(s). Read More »
Company orders additional product amid reported industry shortage Read More »
For patients with non-low back, musculoskeletal injuries, non-steroidal anti-inflammatory drugs should be a first-line treatment for acute pain that lasts no more than four weeks, according to a new guideline from the American College of Physicians and the American Academy of Family Physicians. Read More »
The high costs of medical care are well-documented, but those battling significant illnesses have found a measure of economic relief through manufacturer cost-sharing assistance programs. Read More »
The push for a COVID-19 vaccine is “remarkably positioned to succeed,” Jenny Bryant, executive vice president of policy and research for the Pharmaceutical Research and Manufacturers of America (PhRMA), said. Read More »
Karmanos Specialty Pharmacy (KSP) is pleased to announce that it has received full accreditation from the Utilization Review Accreditation Commission (URAC). This accreditation is valid for three years. Read More »
Company increases U.S. manufacturing capacity of drug to ensure uninterrupted supply amid industry shortage Read More »
The best practices for genetic testing for the management of cardiovascular diseases that are inherited have been outlined by the American Heart Association (AHA). Read More »
A recent letter to Congressional leaders from a coalition headed by the National Forum for Heart Disease and Stroke Prevention urges Congress to include payments for front-line pharmacists in the next COVID-19 relief package by designating them as providers under Medicare Part B. Read More »
Medly Continues Nationwide Expansion With the Launch of Digital Pharmacy Services, Including Free, Same-Day Delivery, Into the Baltimore Market Read More »
The reliability, quality and safety of our nation's drug supply chain are essential to the nation's security and health and well-being of the American public. Read More »
PQS adds former Senior Advisor to the Secretary for Drug Pricing Reform, U.S. Department of Health and Human Services to its Board of Directors Read More »
Humana Pharmacy, a division of Humana Inc. (NYSE: HUM), has been named the best in Mail Order Pharmacy customer satisfaction in the J.D. Power 2020 U.S. Pharmacy Study. It’s the third consecutive year that Humana has received the prestigious honor. Read More »
A recent pilot study conducted by Johns Hopkins Medicine may show promise for lowering cholesterol in some patients by using a drug that inhibits a protein involved in cholesterol metabolism. Read More »
Alerts Sign-up
